We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$8.92B
Cap. Flow
+$6.38B
Cap. Flow %
38.87%
Top 10 Hldgs %
11.97%
Holding
501
New
64
Increased
117
Reduced
241
Closed
32

Top Buys

Rank Stock Value
1
PINS icon
Pinterest
PINS
+$181M
2
CRWD icon
CrowdStrike
CRWD
+$173M
3
RNG icon
RingCentral
RNG
+$166M
4
SNPS icon
Synopsys
SNPS
+$158M
5
WCN
Waste Connections
WCN
+$152M

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Healthcare 20.91%
3 Industrials 14.05%
4 Consumer Discretionary 13.18%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
126
Skyworks Solutions
SWKS
$11.1B
$40.2M 0.24%
263,075
+69,497
+36% +$10.2M
TREX icon
127
Trex
TREX
$4.65B
$39.8M 0.24%
475,627
-112,638
-19% -$8.62M
AVTR icon
128
Avantor
AVTR
$10.1B
$39.6M 0.24%
+1,407,472
New +$36.3M
SLAB icon
129
Silicon Laboratories
SLAB
$7.36B
$39.1M 0.24%
306,961
-11,973
-4% -$1.35M
QDEL icon
130
QuidelOrtho
QDEL
$958M
$39M 0.24%
217,206
+112,156
+107% +$24.9M
CRL icon
131
Charles River Laboratories
CRL
$13.8B
$38.6M 0.24%
+154,537
New +$36.8M
TGT icon
132
Target
TGT
$74.7B
$38.3M 0.23%
216,855
-1,400
-0.6% -$234K
ARWR icon
133
Arrowhead Research
ARWR
$12.2B
$37.6M 0.23%
490,333
-48,163
-9% -$3.08M
CNMD icon
134
CONMED
CNMD
$1.48B
$37.5M 0.23%
334,488
+166,671
+99% +$15.8M
BPMC
135
DELISTED
Blueprint Medicines
BPMC
$37.1M 0.23%
330,384
-34,848
-10% -$3.67M
TXN icon
136
Texas Instruments
TXN
$236B
$36.9M 0.22%
224,867
-1,200
-0.5% -$187K
EBS icon
137
Emergent Biosolutions
EBS
$318M
$36.8M 0.22%
411,186
+12,521
+3% +$1.15M
CCMP
138
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$36.4M 0.22%
240,836
-12,317
-5% -$1.84M
HD icon
139
Home Depot
HD
$320B
$36.2M 0.22%
136,303
-5,500
-4% -$1.51M
LHCG
140
DELISTED
LHC Group LLC
LHCG
$36.1M 0.22%
169,235
-97,205
-36% -$20.7M
EVH icon
141
Evolent Health
EVH
$488M
$36M 0.22%
2,246,832
-69,086
-3% -$913K
AMZN icon
142
Amazon
AMZN
$2.79T
$35.8M 0.22%
220,000
-8,000
-4% -$1.28M
INSM icon
143
Insmed
INSM
$27.6B
$35.8M 0.22%
1,074,867
-89,200
-8% -$3.26M
PLD icon
144
Prologis
PLD
$131B
$35.5M 0.22%
356,671
-30,310
-8% -$3.06M
SMPL icon
145
Simply Good Foods
SMPL
$1.01B
$35.5M 0.22%
1,130,857
-113,936
-9% -$2.65M
SIRI icon
146
SiriusXM
SIRI
$9.77B
$35.4M 0.22%
+556,090
New +$34.1M
MEDP icon
147
Medpace
MEDP
$16.5B
$35.4M 0.22%
254,168
+194,961
+329% +$24.6M
QTWO icon
148
Q2 Holdings
QTWO
$3.87B
$34.8M 0.21%
275,000
-2,580,560
-90% -$278M
AVGO icon
149
Broadcom
AVGO
$1.7T
$34.2M 0.21%
780,410
+212,310
+37% +$8.28M
MRTX
150
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$34.1M 0.21%
155,365
-15,849
-9% -$3.43M

Similar funds

Carillon Tower Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Carillon Tower Advisers held 501 positions worth $16.4B, up 119% from $7.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Carillon Tower Advisers deployed $6.38B of net new capital in Q4 2020, opening 64 new positions and adding to 117 existing holdings. Its largest new stake was Pinterest: 3,021,131 shares worth $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Q2 Holdings, an estimated $278M trimmed.

  • Carillon Tower Advisers's largest Q4 2020 buy was Pinterest: 3,021,131 shares worth $199M.
  • Carillon Tower Advisers added most to CrowdStrike in Q4 2020, an estimated $173M increase.
  • Carillon Tower Advisers's biggest Q4 2020 reduction was Q2 Holdings, cutting an estimated $278M.
  • Carillon Tower Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020, selling an estimated $31.6M.
  • Carillon Tower Advisers's ten largest holdings make up 12% of its $16.4B portfolio in Q4 2020.
  • Carillon Tower Advisers opened 64 new positions and closed 32 in Q4 2020.
  • Carillon Tower Advisers's portfolio value rose 119% quarter-over-quarter to $16.4B.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.